Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL-1β antibody, in patients with type 2 diabetes (Q37022686)
Jump to navigation
Jump to search
scientific article published on 20 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL-1β antibody, in patients with type 2 diabetes |
scientific article published on 20 March 2013 |
Statements
1 reference
Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL-1β antibody, in patients with type 2 diabetes (English)
1 reference
Joanne Sloan-Lancaster
1 reference
Eyas Abu-Raddad
1 reference
John Polzer
1 reference
Jeffrey W Miller
1 reference
Joel C Scherer
1 reference
Andrea De Gaetano
1 reference
Jolene K Berg
1 reference
William H Landschulz
1 reference
20 March 2013
1 reference
1 reference
2239-2246
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference